Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Karol G Postpones Show in Mexico City Due to Health Reasons: Heres the New Date

    November 16, 2026

    Where was Nvidias security team? | TechCrunch

    November 15, 2026

    6 Golden Age Westerns To Watch On Prime Video (That Dont Star John Wayne)

    November 15, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Technology»The Next Great Overdose-Reversing Drug Might Already Exist
    Technology

    The Next Great Overdose-Reversing Drug Might Already Exist

    By AdminDecember 6, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    The Next Great Overdose-Reversing Drug Might Already Exist

    [ad_1]

    Critics say the Schedule I classification is heavy-handed, based on fear rather than evidence. “It bypasses science,” says Maritza Perez, a director at the Drug Policy Alliance, a nonprofit focused on drug policy reform. Frustrated by this blanket ban and eager to develop new overdose treatments, a growing number of scientists, doctors, and other researchers are pushing back. 

    “A classwide ban based on chemical structure alone would preclude a lot of research that could lead to life-saving medications,” says Gregory Dudley, a chemistry professor at West Virginia University and one of the co-authors of the open letter to Biden. In that letter, Dudley and other scientists argue that permanent Schedule I status could “inadvertently criminalize” important tools to fight the overdose crisis.

    Dudley supports a bill introduced last week by US senator Cory Booker (D-New Jersey) called the Temporary Emergency Scheduling and Testing (TEST) Act, which would temporarily extend Schedule I classification again but also require the government to evaluate individual fentalogs, descheduling those with therapeutic uses or without risk of abuse. Booker is hopeful he can pitch his bill as a common-sense approach to the issue. “This bill strikes a middle ground to ensure that we are doing all we can to save lives,” he told WIRED by email. 

    Even some experts who support permanent scheduling recognize that the status quo doesn’t work. “I believe that the fentanyl-related substances should be permanently put into Schedule I. But I also very strongly believe that the research on Schedule I drugs—and this is more than just the fentanyl-related substances—should be made easier,” says Victor Weedn, a forensic pathologist and professor at George Washington University. In addition to fentalogs, drugs like cannabis and psilocybin are also classified as Schedule I, which has impeded research on those substances as well.

    The discovery of a new overdose-reversal medication would be a major victory for public health. Naloxone—often referred to by its brand name, Narcan—is currently the only drug widely available for reversing opioid overdoses. Molecularly similar to the opioid oxymorphone, naloxone works by binding to opioid receptors, blocking the effects of other opioids. It isn’t a silver bullet, but it has become an important tool for keeping people alive. It is often in short supply, though—and can be expensive.

    “Anything we can do that would increase the variability of products on the market could potentially help overcome supply chain issues and hopefully drive down prices,” says Stacy McKenna, a harm reduction fellow at the libertarian-leaning think tank the R Street Institute. “And there might be something that works better to help reverse fentanyl overdoses.”

    While naloxone can reverse fentanyl overdoses, it’s not always as effective as it is with less-powerful opioids. “One problem is re-narcotization,” Traynor says. A dose of naloxone that would revive someone who took too much heroin might wear off for someone who took fentanyl, causing their overdose symptoms to return. This means multiple doses of naloxone can be necessary to stop fentanyl overdoses—bad news for people who might have just a single dose at hand. If there’s another option out there more efficient at specifically reversing fentanyl overdoses, it could have a seismic lifesaving effect.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleAdélie penguins show signs of self-awareness on the mirror test
    Next Article iPad sale: Apple’s newest tablet is at an all-time low price

    RELATED POSTS

    Where was Nvidias security team? | TechCrunch

    November 15, 2026

    Amazons new Kindle Colorsoft is a premium e-reader with a premium price | TechCrunch

    November 14, 2026

    Uber confirms hackers stole thousands of drivers license information in data breach | TechCrunch

    November 13, 2026

    Cyberattack on Fireworks AI allowed hackers to access Notion customers chat transcripts | TechCrunch

    November 12, 2026

    Siri co-founder backs Helix for its voice ID tech | TechCrunch

    November 11, 2026

    Reddit is turning user conversations into AI-powered product reviews | TechCrunch

    November 10, 2026
    latest posts

    Karol G Postpones Show in Mexico City Due to Health Reasons: Heres the New Date

    The third concert that Karol G was set to perform on Sunday (Nov. 15) at…

    Where was Nvidias security team? | TechCrunch

    November 15, 2026

    6 Golden Age Westerns To Watch On Prime Video (That Dont Star John Wayne)

    November 15, 2026

    Watch Travis Barker and Cynthia Erivo perform In The Air Tonight as Phil Collins tells Rock & Roll Hall Of Fame: You havent heard the last of me

    November 15, 2026

    SNL Cold Open: Bowen Yang Returns as Jensen Huang to Roast Tech Billionaires

    November 15, 2026

    Listen to the River! Arrow for a Stone Heart Is a Poetic Hybrid Experience Told Through an Indigenous Lens

    November 15, 2026

    Roseanne Barrs Ex-Husband Makes Shocking Sex Admission

    November 15, 2026
    Categories
    • Books (1,589)
    • Business (6,481)
    • Events (85)
    • Film (6,449)
    • Lifestyle (4,501)
    • Music (6,582)
    • Politics (6,447)
    • Science (5,850)
    • Technology (6,437)
    • Television (6,141)
    • US News (6,486)
    popular posts

    Cupping for Cellulite? Why An Expert Loves This Approach

    [ad_1] If someone hasn’t told you lately: cellulite is entirely normal—and more common than you…

    A Different Kind of Holiday Affair: Carol at 10

    December 11, 2025

    Rachel Maddow Shatters The Big Lie That Business Supports Trump

    June 25, 2024

    Iron & Wine and Band of Horses’ Ben Bridwell Cover Kendrick Lamar and SZA’s “Luther”: Listen

    July 31, 2025
    Archives
    Browse By Category
    • Books (1,589)
    • Business (6,481)
    • Events (85)
    • Film (6,449)
    • Lifestyle (4,501)
    • Music (6,582)
    • Politics (6,447)
    • Science (5,850)
    • Technology (6,437)
    • Television (6,141)
    • US News (6,486)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Listen to the River! Arrow for a Stone Heart Is a Poetic Hybrid Experience Told Through an Indigenous Lens

    November 15, 2026

    Roseanne Barrs Ex-Husband Makes Shocking Sex Admission

    November 15, 2026

    New Young Adult Books Readers Are Talking About – NewInBooks

    November 14, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT